ITCI

Intra-Cellular Therapies Inc.
ITCI

Overview Fund Activity
Delisted

ITCI was delisted on the 1st of April, 2025.

Back to rankings

35 hedge funds and large institutions have $201M invested in Intra-Cellular Therapies Inc. in 2014 Q1 according to their latest regulatory filings, with 35 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
35
Holders Change
+35
Holders Change %
–
% of All Funds
1.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
35
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$79.7M
2
BA
2
BlackRock Advisors
Delaware
$19.3M
3
RG
3
Redmile Group
California
$18.2M
4
Franklin Resources
4
Franklin Resources
California
$15.3M
5
VAM
5
Visium Asset Management
New York
$12.7M

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
EEG
26
E.E. Geduld
$364K 20,030 +20,030 New
SCA
27
SAC Capital Advisors
Connecticut
$348K 19,139 +19,139 New
Charles Schwab
28
Charles Schwab
California
$346K 18,996 +18,996 New
Millennium Management
29
Millennium Management
New York
$287K 15,781 +15,781 New
State Street
30
State Street
Massachusetts
$278K 15,300 +15,300 New
BIT
31
BlackRock Institutional Trust
California
$111K 6,094 +6,094 New
ST
32
Stifel Trust
Missouri
$46K 2,500 +2,500 New
U
33
UBS
Switzerland
$33K 1,842 +1,842 New
TRCT
34
Tower Research Capital (TRC)
New York
$11K 593 +593 New
Barclays
35
Barclays
United Kingdom
$2K 100 +100 New
1
2